Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Weekly vs Daily Zicronapine in Schizophrenia
NCT01377233Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Jul 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zicronapine in schizophrenia, sponsored by Lundbeck. Started Jul 2011; status: completed.
02
Drugs
zicronapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01377233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377233.